FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ACTOS (pioglitazone) filed by Takeda Pharmaceuticals America, Inc., authorizing a modification to the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)

Snippet

SUPPL AP for ACTOS (PIOGLITAZONE)